e-learning
resources
Munich 2014
Wednesday, 10.09.2014
Lung function, COPD and inflammation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Arterial stiffness is increased in subjects with COPD stage 3-4
U. Nilsson, L. Quist, K. Larsson, B. Lundbäck, V. Johansson, E. Rönmark, A. Blomberg, A. Lindberg (Umeå, Luleå, Stockholm, Gothenburg, Sweden)
Source:
International Congress 2014 – Lung function, COPD and inflammation
Session:
Lung function, COPD and inflammation
Session type:
Poster Discussion
Number:
4762
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
U. Nilsson, L. Quist, K. Larsson, B. Lundbäck, V. Johansson, E. Rönmark, A. Blomberg, A. Lindberg (Umeå, Luleå, Stockholm, Gothenburg, Sweden). Arterial stiffness is increased in subjects with COPD stage 3-4. Eur Respir J 2014; 44: Suppl. 58, 4762
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on acute decompensated pulmonary hypertension
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Relationship between endothelial dysfunction and GOLD stage in patients with COPD
Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD
Year: 2016
Pulse wave velocity in patients with COPD comorbid with arterial hypertension
Source: International Congress 2014 – COPD exacerbations
Year: 2014
Comorbidities and COPD severity: The French Palomb cohort
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016
Comorbidities, gender-differences and COPD severity: The French Palomb cohort
Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD
Year: 2015
Relation of American Heart Association’s life’s simple 7 cardiovascular health factors with chronic obstructive pulmonary disease
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016
Association between airflow obstruction and arterial stiffness
Source: Annual Congress 2013 –Comorbidities and respiratory disease and late-breaking abstracts
Year: 2013
Does Nutritional Risk Screening 2002 correlate with dyspnea status of patients with GOLD stage 3-4 chronic obstructive pulmonary disease: a Cohort study.
Source: International Congress 2018 – Nutrition and metabolic syndrome in COPD
Year: 2018
Associations between severity of airflow obstruction and atherosclerosis: A cross-sectional study in Japan
Source: International Congress 2014 – Prevalence of COPD and mortality from COPD
Year: 2014
Cardiovascular status of patients with a severe form of COPD
Source: International Congress 2015 – Diagnosing and management of COPD in primary care
Year: 2015
Characteristics and outcomes of GOLD C and D COPD patients
Source: International Congress 2014 – Longitudinal studies of respiratory disease
Year: 2014
Characteristics of essential hypertension in COPD patients
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
Prevalence of comorbidities in patients with COPD: Data from the TOPDOCS cohort
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013
Diabetes mellitus type 2 in patients with COPD admitted for exacerbation: Preliminary data
Source: International Congress 2014 – Respiratory disease within hospital-based populations
Year: 2014
Cardiovascular comorbidities of COPD in never-smokers
Source: International Congress 2014 – Highlights in respiratory epidemiology
Year: 2014
24-hour arterial stiffness monitoring values in patients with COPD
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013
Mortality associated with the type of heart failure in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – COPD and asthma COPD overlap syndrome (ACOS): novelties in terms of prevalence, risk factors, and prognosis in COPD
Year: 2016
Prevalence of self-reported heart disease and ischemic ECG changes in COPD and non-COPD
Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD
Year: 2015
Cardiovascular diseases (CVD), arterial hypertension (AH) and diabetes mellitus (DM) in a cohort of 609 COPD patients: Associations with the new GOLD classification 2011
Source: Annual Congress 2013 –Quality of life and respiratory symptoms in primary care COPD populations
Year: 2013
Pulmonary arterial hypertension patients underrepresented in clinical trials – Are they different?
Source: International Congress 2016 – Pulmonary hypertension: the clinic II
Year: 2016
Ischemic ECG changes are related to mortality among subjects with COPD
Source: International Congress 2016 – COPD and asthma COPD overlap syndrome (ACOS): novelties in terms of prevalence, risk factors, and prognosis in COPD
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept